Modern Medicine News

Targeted treatments for atopic dermatitisEmerging treatments are expected to help fill the need for safer and more effective therapies for atopic dermatitis (AD). Both systemic and topical treatments are needed to provide full and complete treatment for patients with AD. Targeting the specific axis or axes that control AD may contribute to developing personalized approaches to treatment
Accelerating skin disease researchAvailable resources of the Center include human pathology specimens and database info on living consented patients. Techniques such as tissue imaging, gene expression analysis, T-cell receptor, sequencing studies, and CyTOF analyses are available. Visiting Scholar grants funds allow researchers to learn how to work with human tissue and how to use new techniques.
The false security of a full scheduleIt is not uncommon to hear people talk about the health of their practices by confidently stating how far they are “booked out.” How long it takes for a patient to get an appointment is often a statement of practice wellness.
Upgrade your patients to new technologyWith much of the digital revolution occurring after 2008 and most contact lens technology developing well before it, there is an inherent design feature mismatch. The majority of the available contact lenses are not designed for how patients are using their eyes.
Primary care physicians react to AHCA
Primary care physicians react to AHCAFrom calling it “a step backward” to “complex and confusing,” primary care physicians told Medical Economics they have doubts about GOP healthcare reform plans.
Artificial intelligence could create smarter EHRsAI will be an increasingly important player in healthcare IT, with better medical care being an expected benefit.
EHRs open opportunities for clinical trials, research participationSystems allow physicians and their patients to more easily identify relevant studies, although working such alerts into workflow can be challenging
Novel neurostimulator device uses nasal cavities to stimulate tearsChronic dry eye disease (DED) affects more than 25 million people and to date the only pharmacologic therapies are topical or involve punctal plugs. Results from two studies wth a neurostimulator indicate there may be a new pathway to upregulate the body’s tear system.
Bimatoprost insert offers noninvasive platform for early glaucoma patients A 19-month, open-label study of a novel bimatoprost, sustained-release ocular insert shows good safety and efficacy. The insert is polymer ring that sits atop the eye in the conjunctival fornix. Phase III trials are expected to begin in 2017.
Phyician-patient dynamic reshaped in era of EHRIs your electronic health record (EHR) less than magical? Part of the problem may be how you are using it.